etidronate has been researched along with Hospital-Acquired Condition in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vestergaard, P | 1 |
Schwartz, K | 1 |
Pinholt, EM | 1 |
Rejnmark, L | 1 |
Mosekilde, L | 1 |
Hoppé, E | 1 |
Masson, C | 1 |
Laffitte, A | 1 |
Chappard, D | 1 |
Audran, M | 1 |
2 other studies available for etidronate and Hospital-Acquired Condition
Article | Year |
---|---|
Gastric and esophagus events before and during treatment of osteoporosis.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Causality; Clodroni | 2010 |
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Topics: Aged, 80 and over; Alkaline Phosphatase; Biopsy; Bone Density Conservation Agents; Calcification, Ph | 2012 |